{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/266907147"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "In that model, the following were associated with the development of metabolic syndrome in the first 2 years, along with peak prednisone dose: Previous metabolic syndrome, OR 4.83 (95% CI 2.93 to 7.87) Elevated anti-dsDNA antibodies, OR 1.86 (95% CI 1.19 to 2.81) Age, OR 1.03 (95% CI 1 to 1.05) Hispanic ethnicity, OR 3.47 (95% CI 1.76 to 6.86) But factors such as age and ethnicity are not modifiab" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "medpagetoday.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/214521122"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/266907147" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/136572905"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/266907147"] } } }
